About: OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers and other diseases. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3-kinase alpha (PI3Ka) harboring the H1047R mutation that is in Phase 1 clinical trial for the treatment of solid tumors, including breast cancer. The company was founded in 2011 and is headquartered in Boulder, Colorado.
Sector: Healthcare
Industry: Biotechnology
Latest price: $3.06 (+3.73%)
OKUR NASDAQ OnKure Therapeutics, Inc.
OnKure Therapeutics, Inc. share price
OKUR price activity
Last Price
$3.000
Change (24hr)
0.05 USD (1.69%)
Volume
62.99K
Volume (4w avg)
-
Open
$2.95
Day Range
$2.92 - $3.10
Previous Close
$2.95
Last Trade
21 Sep, 3:34 pm GMT+0
Delayed
21 Sep, 3:34 pm GMT+0
OKUR price performance
Delayed
21 Sep, 3:34 pm GMT+0
OKUR Market Signals